.
MergerLinks Header Logo

New Deal

New Deal

Announced

Completed

GUARDANT HEALTH INC / SOFTBANK GROUP CORP / Acquisition / Private / £247m

Financials

Edit Data
Transaction Value£86m
Consideration Type-
Capital Owned-
Capital Bid For35%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Guardant Health

target

Guardant Health

Softbank Group Corp

bidder

Softbank Group Corp

Sources

Edit

Tags

Edit

medical devices

genomics

biotechnology

Biotechnology

Private

Acquisition

Completed

Friendly

Single Bidder

United States

Synopsis

Edit

Sale of a 35% stake in Guardant Health, a provider of sequencing and rare-cell diagnostics services focusing on cancer, to Softbank Group Capital.

Service Providers (1)

Dealmakers

Latham & Watkins

legal advisors

Latham & Watkins

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US